Roger Franklin
Directeur/Membre du Conseil chez ABLIVA AB
Profil
Roger Franklin is currently a Director at Abliva AB and a Director at Gesynta Pharma AB.
He is also a Deputy Director at HVentures Capital i AB, a Director at TargED Biopharmaceuticals BV, a Deputy Director at HVentures Capital II AB, a Director at Crosslanes Holding AB, and a Partner at Hadean Ventures AS.
Previously, he was a Deputy Director at SAGA Diagnostics AB and an Analyst at Liberum Capital Ltd.
from 2010 to 2018.
He received his undergraduate degree from the University of Oxford and his doctorate from the University of Cambridge.
Postes actifs de Roger Franklin
| Sociétés | Poste | Début |
|---|---|---|
| ABLIVA AB | Directeur/Membre du Conseil | 20/05/2020 |
Hadean Ventures AS
 Hadean Ventures AS Investment ManagersFinance Hadean Ventures AS (Hadean Ventures) is a venture capital firm that manages alternative investment funds. The firm was founded by Ingrid Helene Teigland Akay in 2014 and is headquartered in Oslo, Norway. | Private Equity Investor | - |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Directeur/Membre du Conseil | - |
| Crosslanes Holding AB | Directeur/Membre du Conseil | - |
TargED Biopharmaceuticals BV
 TargED Biopharmaceuticals BV BiotechnologyHealth Technology TargED Biopharmaceuticals BV is a Dutch company that develops biological drugs. The company is based in Utrecht, Netherlands. The company was founded by Coen Maas, Kristof Vercruysse, Marc van Moorsel, Steven de Maat. Kristof Vercruysse has been the CEO since incorporation. | Directeur/Membre du Conseil | - |
HVentures Capital i AB
 HVentures Capital i AB Investment ManagersFinance HVentures Capital i AB provides private equity fund services. The private company is based in Stockholm, Sweden. | Corporate Officer/Principal | - |
HVentures Capital II AB
 HVentures Capital II AB Investment ManagersFinance HVentures Capital II AB invests in companies located in Europe. The fund targets companies operating in the field of the healthcare. It provides financing for early stage of capital requirements. | Corporate Officer/Principal | - |
Anciens postes connus de Roger Franklin
| Sociétés | Poste | Fin |
|---|---|---|
Liberum Capital Ltd.
 Liberum Capital Ltd. Investment Banks/BrokersFinance Liberum Capital Ltd. (Liberum) is the Great Britain-based brokerage subsidiary of TN Holdings (BVI) Ltd. in British Virgin Islands. The firm was founded in 2007 by Shane Le Prevost. Headquartered in London, Liberum provides trading and execution services for institutional clients. They bring liquidity into the niches that matter and are market-makers in more than 350 large, mid and small-cap stocks. | Analyst-Equity | 31/10/2018 |
SAGA Diagnostics AB
 SAGA Diagnostics AB Medical/Nursing ServicesHealth Services Saga Diagnostics AB operates as a personalized cancer medicine and disease monitoring company. The firm's services include Gene Mutation analysis, circulating tumor DNA and Chromosome analysis. The company was founded by Lao Saal and Anthony George in 2016 and is headquartered in Lund, Sweden. | Corporate Officer/Principal | - |
Formation de Roger Franklin
| University of Oxford | Undergraduate Degree |
| University of Cambridge | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABLIVA AB | Health Technology |
| Entreprise privées | 8 |
|---|---|
Liberum Capital Ltd.
Liberum Capital Ltd. Investment Banks/BrokersFinance Liberum Capital Ltd. (Liberum) is the Great Britain-based brokerage subsidiary of TN Holdings (BVI) Ltd. in British Virgin Islands. The firm was founded in 2007 by Shane Le Prevost. Headquartered in London, Liberum provides trading and execution services for institutional clients. They bring liquidity into the niches that matter and are market-makers in more than 350 large, mid and small-cap stocks. | Finance |
Hadean Ventures AS
Hadean Ventures AS Investment ManagersFinance Hadean Ventures AS (Hadean Ventures) is a venture capital firm that manages alternative investment funds. The firm was founded by Ingrid Helene Teigland Akay in 2014 and is headquartered in Oslo, Norway. | Finance |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Health Technology |
SAGA Diagnostics AB
SAGA Diagnostics AB Medical/Nursing ServicesHealth Services Saga Diagnostics AB operates as a personalized cancer medicine and disease monitoring company. The firm's services include Gene Mutation analysis, circulating tumor DNA and Chromosome analysis. The company was founded by Lao Saal and Anthony George in 2016 and is headquartered in Lund, Sweden. | Health Services |
| Crosslanes Holding AB | |
TargED Biopharmaceuticals BV
TargED Biopharmaceuticals BV BiotechnologyHealth Technology TargED Biopharmaceuticals BV is a Dutch company that develops biological drugs. The company is based in Utrecht, Netherlands. The company was founded by Coen Maas, Kristof Vercruysse, Marc van Moorsel, Steven de Maat. Kristof Vercruysse has been the CEO since incorporation. | Health Technology |
HVentures Capital i AB
HVentures Capital i AB Investment ManagersFinance HVentures Capital i AB provides private equity fund services. The private company is based in Stockholm, Sweden. | Finance |
HVentures Capital II AB
HVentures Capital II AB Investment ManagersFinance HVentures Capital II AB invests in companies located in Europe. The fund targets companies operating in the field of the healthcare. It provides financing for early stage of capital requirements. | Finance |